Under glucose/glutamine-deprived conditions, overexpressed cMYC also activates the serine biosynthesis pathway to adopt metabolic switch through transcriptionally upregulated the final rate-limiting enzyme phosphoserine phosphatase in both HCC cell lines and xenograft mouse models [85]. The gene discussed is MYC; the disease is hepatocellular carcinoma.